BiotechTube

14C-labeled YM178

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Metabolic Processes

Conditions

Metabolic Processes

Trial Timeline

Jan 1, 2003 → Feb 1, 2003

NCT ID
NCT01651312

About 14C-labeled YM178

14C-labeled YM178 is a phase 1 stage product being developed by Astellas Pharma for Metabolic Processes. The current trial status is completed. This product is registered under clinical trial identifier NCT01651312. Target conditions include Metabolic Processes.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01651312Phase 1Completed

Competing Products

20 competing products in Metabolic Processes

See all competitors
ProductCompanyStageHype Score
Telmisartan 40mg + Rosuvastatin 20mg + Telmisartan 80mg + Rosuvastatin 20mg + Telmisartan 40mg, 80 mg + Rosuvastatin 20mgYuhanApproved
85
Olmesartan medoxomil tablets low dose + Olmesartan medoxomil tablets high dose + AmlodipineDaiichi SankyoPhase 3
77
olmesartan medoxomil + placebo + olmesartan medoxomil + olmesartan medoxomilDaiichi SankyoPhase 3
77
TRC150094Torrent PharmaceuticalsPhase 1/2
41
LY518674Eli LillyPhase 2
52
Tirzepatide + Retatrutide + PlaceboEli LillyPhase 3
77
Metformin + PlaceboEli LillyApproved
85
Tirzepatide + SemaglutideEli LillyPre-clinical
23
LY3849891 + PlaceboEli LillyPhase 1
33
Henagliflozin 10 mg daily + Metformin 1700 mg dailyJiangsu Hengrui MedicineApproved
85
RosuvastatinAstraZenecaPhase 3
77
Rosuvastatin + AtorvastatinAstraZenecaApproved
85
AZD2693 + PlaceboAstraZenecaPhase 1
33
RosuvastatinAstraZenecaPhase 3
77
Rosuvastatin + AtorvastatinAstraZenecaPhase 3
77
rosuvastatinAstraZenecaApproved
85
EfinopegdutideMerckPhase 2
52
MK0767 + Comparator: fenofibrate + Comparator: Placebo (unspecified)MerckPhase 2
52
Vericiguat + PlaceboMerckPhase 2
52
MetforminMerckPhase 2
52

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85